44S-28538-22009
3 vaccinations
2 coded responses
7 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 070 / NJ
- Registered
- 2022-04-25
- Relationship
- Child or adolescent in my care
- Guardian
- S75-10969-63626
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-29
Dose 1 — Pfizer-BioNTech
-
2021-08-20
Dose 2 — Pfizer-BioNTech
-
2022-04-04
Dose 3 — Pfizer-BioNTech
-
2022-04-25
Registered in v-safe
- 2022-04-25
- 2022-05-02
- 2022-05-09
- 2022-05-16
- 2022-07-06
-
2022-10-03
Survey response — 6 months, dose 3, dependentMedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Picked up a cold from school. Rapid and PCR COVID tests all came back negative.MedDRA releases: 2024-11 · check-in free text available
-
2023-04-04
Survey response — 12 months, dose 3, dependentMedDRA: SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-29 | Pfizer-BioNTech | No |
| 2 | 2021-08-20 | Pfizer-BioNTech | No |
| 3 | 2022-04-04 | Pfizer-BioNTech | No |
Free text
Release 12 — 6 months, dose 3, dependent
Symptoms: Picked up a cold from school. Rapid and PCR COVID tests all came back negative.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release